Related Experiment Video
Updated: Oct 2, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Diagnostic Delay and Its Predictors in Cluster Headache
Byung-Su Kim1, Pil-Wook Chung2, Byung-Kun Kim3
1Department of Neurology, Daejin Medical Center, Bundang Jesaeng General Hospital, Seongnam, South Korea.
Insights
Younger patients with cluster headache (CH) face longer diagnostic delays, impacting their disease burden. Improved diagnostic criteria and education have reduced delays over time.
Area of Science:
- Neurology
- Headache Medicine
Background:
- Cluster headache (CH) is a rare, debilitating primary headache disorder.
- Delayed diagnosis of CH exacerbates patient suffering and disease burden.
Purpose of the Study:
- To investigate the diagnostic delay in cluster headache patients.
- To identify predictors of diagnostic delay and its clinical impact.
Main Methods:
- Analysis of data from a 4-year prospective multicenter CH registry.
- Diagnosis of CH based on International Classification of Headache Disorders (ICHD)-3 criteria.
- Assessment of diagnostic delay as time from onset to diagnosis, categorized into tertiles.
Main Results:
- Mean diagnostic delay was 5.7 years; younger patients (<20 years) had higher delays.
- Episodic, chronic, and probable CH were associated with longer diagnostic delays.
- Increased diagnostic delay correlated with higher prevalence of suicidal ideation and HIT-6 scores.
Conclusions:
- Younger age of onset is a significant predictor of delayed CH diagnosis.
- Improved diagnostic criteria (ICHD) and patient education have reduced diagnostic delays over time.
- Reducing diagnostic delay is crucial for mitigating the disease burden of cluster headache.
Objective:
Cluster headache (CH) is a rare, primary headache disorder, characterized of excruciating, strictly one-sided pain attacks and ipsilateral cranial autonomic symptoms. Given the debilitating nature of CH, delayed diagnosis can increase the disease burden. Thus, we aimed to investigate the diagnostic delay, its predictors, and clinical influence among patients with CH.
Methods:
Data from a prospective multicenter CH registry over a 4-year period were analyzed. CH was diagnosed according to the International Classification of Headache Disorders (ICHD)-3 criteria, and diagnostic delay of CH was assessed as the time interval between the year of the first onset and the year of CH diagnosis. Patients were classified into three groups according to the tertiles of diagnostic delay (1st tertile, <1 year; 2nd tertile, 1-6 years; and 3rd tertile, ≥7 years).
Results:
Overall, 445 patients were evaluated. The mean duration of diagnosis delay was 5.7 ± 6.7 years, (range, 0-36 years). Regarding the age of onset, majority of young patients (age <20 years) belonged to the third tertile (60%), whereas minority of old patients (>40 years) belonged to the third tertile (9.0%). For year of onset, the proportion of patients in the 3rd tertile was the highest for the groups before the publication year of the ICHD-2 (74.7%) and the lowest for the groups after the publication year of the ICHD-3 beta version (0.5%). Compared with the first CH, episodic CH [multivariable-adjusted odds ratio (aOR) = 5.91, 95% CI = 2.42-14.48], chronic CH (aOR = 8.87, 95% CI = 2.66-29.51), and probable CH (aOR = 4.12, 95% CI = 1.48-11.43) were associated with the tertiles of diagnostic delay. Age of onset (aOR = 0.97, 95% CI = 0.95-0.99) and PHQ-9 score (aOR = 0.96, 95% CI = 0.93-0.99) were inversely associated with the tertile of diagnostic delay. The prevalence of suicidal ideation was highest in the patients of the third tertile. The mean HIT-6 score increased significantly with the diagnostic delay (p = 0.041).
Conclusions:
Patients with a younger onset of CH have a higher risk of diagnostic delay. Nevertheless, the rate of delayed diagnosis gradually improved over time and with the publication of the ICHD criteria, supporting the clinical significance of diagnostic clinical criteria and headache education to reduce the disease burden of CH.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Aneurysm II: Clinical Manifestations and Diagnostic Studies

